A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.

Autor: Hannani D; PDC*line Pharma, 38000 Grenoble, France., Leplus E; PDC*line Pharma, 38000 Grenoble, France., Laurin D; Recherche et Développement, EFS, 38000 Grenoble, France.; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Caulier B; Recherche et Développement, EFS, 38000 Grenoble, France.; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Aspord C; Recherche et Développement, EFS, 38000 Grenoble, France.; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Madelon N; Recherche et Développement, EFS, 38000 Grenoble, France.; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Bourova-Flin E; Groupe EpiMed, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Brambilla C; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France.; Centre Hospitalo-Universitaire Grenoble-Alpes, Université Grenoble-Alpes, 38000 Grenoble, France., Brambilla E; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France.; Centre Hospitalo-Universitaire Grenoble-Alpes, Université Grenoble-Alpes, 38000 Grenoble, France., Toffart AC; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France.; Centre Hospitalo-Universitaire Grenoble-Alpes, Université Grenoble-Alpes, 38000 Grenoble, France., Laulagnier K; PDC*line Pharma, 38000 Grenoble, France., Chaperot L; Recherche et Développement, EFS, 38000 Grenoble, France.; Institute for Advanced Biosciences, Université Grenoble-Alpes, INSERM U1209, CNRS UMR 5309, 38000 Grenoble, France., Plumas J; PDC*line Pharma, 38000 Grenoble, France.; Recherche et Développement, EFS, 38000 Grenoble, France.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 18; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 18.

Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases.

Autor: Wang, Ling¹ (AUTHOR), Zhang, Xiaoyan¹ (AUTHOR), Yang, Ziyi¹ (AUTHOR), Wang, Binquan¹ (AUTHOR), Gong, Hongyang¹ (AUTHOR), Zhang, Ke¹ (AUTHOR), Lin, Yi¹ (AUTHOR), Sun, Mingkuan¹ (AUTHOR) sunmk@njmu.edu.cn

Publikováno v: Translational Neurodegeneration. 12/6/2024, Vol. 13 Issue 1, p1-25. 25p.

Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications.

Autor: Zuo, Jing¹ (AUTHOR), Yan, Han² (AUTHOR), Qin, Siyuan¹ (AUTHOR), Yan, Yonghao¹ (AUTHOR), Wang, Shiqi¹ (AUTHOR), Yang, Li^3,4 (AUTHOR) yangli_hx@scu.edu.cn, Yang, Jinlin^3,4 (AUTHOR) yangjinlin@wchscu.cn, Yang, Jun⁵ (AUTHOR) yangjun6@kmmu.edu.cn

Publikováno v: Medcomm: Oncology. Dec2024, Vol. 3 Issue 4, p1-24. 24p.

The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases.

Autor: Ghosh, Mousumi^1,2,3 (AUTHOR) dpearse@med.miami.edu, Pearse, Damien D.^1,2,3,4,5 (AUTHOR)

Publikováno v: Cells (2073-4409). Nov2024, Vol. 13 Issue 22, p1834. 34p.

Organoids and organoid extracellular vesicles-based disease treatment strategies.

Autor: Zhou, Guangyin^1,2,3 (AUTHOR), Li, Ruiyang^2,4 (AUTHOR), Sheng, Shihao⁴ (AUTHOR), Huang, Jingtao⁵ (AUTHOR), Zhou, Fengjin⁶ (AUTHOR) xarcsh@164.com, Wei, Yan^1,2,3 (AUTHOR) ywei@shu.edu.cn, Liu, Han^1,2,3,4 (AUTHOR) liuhanqiu@shu.edu.cn, Su, Jiacan^1,2,3,4 (AUTHOR) drsujiacan@163.com

Publikováno v: Journal of Nanobiotechnology. 11/6/2024, Vol. 22 Issue 1, p1-21. 21p.